Does diabetes therapy influence the risk of cancer?
Smith
U
U
Gale
E A M
EA
D000818:Animals; D001943:Breast Neoplasms / Q000453:epidemiology / Q000401:mortality; D003110:Colonic Neoplasms / Q000453:epidemiology / Q000401:mortality; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000235:genetics; D019143:Evolution, Molecular; D005260:Female; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives / Q000235:genetics; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000235:genetics; D008297:Male; D009369:Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000401:mortality; D010190:Pancreatic Neoplasms / Q000453:epidemiology / Q000401:mortality; D011471:Prostatic Neoplasms / Q000648:ultrastructure; D017526:Receptor, IGF Type 1 / Q000235:genetics; D011972:Receptor, Insulin / Q000235:genetics; D011994:Recombinant Proteins / Q000009:adverse effects; D012307:Risk Factors; D012377:Rodentia
D007328:Insulin; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin